Abstract
The term "Drug Rash with Eosinophilia and Systemic Symptoms" (DRESS) syndrome was first described in 1996 by Bocquet et al. (1) as a severe adverse drug reaction. DRESS syndrome is classified as one form of severe cutaneous adverse reactions (SCARs). In addition to DRESS syndrome, SCARs includes four other drug-induced skin reactions, the StevensJohnson syndrome (SJS); Toxic epidermal necrolysis (TEN), Stevens-Johnson/toxic epidermal necrolysis overlap syndrome (SJS/TEN); and Acute generalized exanthematous pustulosis (AGEP) 2. DRESS syndrome most commonly manifests two to eight weeks after starting the offending medicine, with a mean onset of three weeks 3 . DRESS syndrome is a delayed type IVb hypersensitivity reaction. The clinical triad consists of fever, skin rash and internal organ involvement. Laboratory tests usually show haematological disturbances including eosinophilia and atypical lymphocytes.
The estimated incidence of this potentially life threatening syndrome was reported in a range from 1 in 1,000 to 1 in 10,000 drug exposures, with a mortality rate up to 10%, mostly caused by fulminant liver failure 4 . The drugs most often implicated are anticonvulsants, bupropion, sulfonamides, sulfasalazine, allopurinol, minocycline, abacavir and neviparine. Prompt clinical recognition and discontinuing suspected medicines helps to minimise morbidity and mortality associated with this syndrome. Systemic steroids are commonly used as well but no controlled clinical trials assess the efficacy of this treatment 5 .
Here, we are presenting a case report of a 58 year old male presented with short history of high grade fever with extensive skin rash & gross eosinophilia. He had a history of taking Carbamazepine for seizure disorder for more than last 3 months. We labelled him as DRESS syndrome & treated accordingly. Case report: Our patient was a 58-year-old diabetic, hypertensive, Muslim male, presented to Medicine OPD with the complaints of fever for 6 days, generalized itchy reddish rash for 3 days, anorexia, nausea, generalized weakness, severe sole pain with walking difficulties for 2 days. His fever was high grade, highest recorded temperature was 104 ae% F. It was initially associated with chills & rigor. There was no respiratory, abdominal or urinary complain associated with fever. His diabetes & hypertension was well controlled with medications. He was taking Carbamazepine for some abnormal motor movements prescribed by his neurologist for more than last 3 months.
Bangladesh
Examination revealed, the patient was febrile, toxic, flushed in appearance. He was alert & well oriented. There was diffuse erythematous maculopapular rash involving trunk & extremities. He had facial & periorbital oedema. Initially, his palms & soles were spared, but later on, after 2 days of hospitalization, there was erythematous scaly rash involving his palms & soles also. There was pedal oedema. On admission, his systemic examination was unremarkable.
After getting leucocytosis, we started broad spectrum antibiotics along with antihistamin for itching. But 2 days after hospitalization, there was no improvement, rather his condition deteriorated. He was still febrile, toxic, flushed, having facial oedema. Rash increased, involving his palms & soles. There was cheilitis, he was unable to eat adequately. He developed dry cough. Examination revealed coarse crackles at lung base (left side); which was initially clear. We reviewed CBC, which revealed 35% Eosinophil count. FDP & D-dimer were raised.
Fever with extensive rash with gross eosinophilia along with history of carbamazepine intake pointed towards the diagnosis of DRESS syndrome. Carbamazepine was stopped on admission .After labelling the patient as DRESS syndrome, we started high dose systemic steroid ( Intravenous Methyl prednisolone for 3 days, followed by oral Deflazacort).
Just after a day of starting systemic steroid, his condition improved dramatically. Gradually he became afebrile, rashes started to resolve, his general wellbeing improved. Laboratory parameters also improved, Eosinophil count came down to 1%. 
Discussion:
DRESS syndrome is an often under-diagnosed and under-recognized severe type IV (delayed type) hypersensitivity reaction that can occur with any medication but most commonly in response to aromatic anticonvulsants 6 . The diagnosis of DRESS syndrome is mainly clinical. The latency period, diversity of symptoms, and exclusion of similar nondrug-induced conditions should be under consideration. Multiple diagnostic criteria have been developed and used in order to standardize the diagnosis and management of DRESS, albeit with limited success. The RegiSCAR group suggested criteria for hospitalized patients with a drug rash to diagnose DRESS syndrome.
RegiSCAR criteria for diagnosis of DRESS 7 Early recognition of the adverse drug reaction and discontinuation of offending medication are essential steps in limiting the progression of DRESS syndrome, as we have done in our case. Pharmacological treatment of DRESS syndrome has to date not been studied with randomized controlled trials and instead has been established on the basis of case reports and retrospective analysis. The French Society of Dermatology published a report in 2010 outlining a consensus on therapeutic management of DRESS syndrome 8 . They recommend the use of systemic corticosteroids at a dose equivalent to one mg/kg/ day of prednisone in patients with any sign of severity. If symptoms continue to progress despite the use of corticosteroids, other options include intravenous immunoglobulin (IVIG) and/or plasmapheresis 9 . Our patient responded well both clinically & biochemically after starting treatment with high dose systemic steroid in the form of Methyl prednisolone.
As the diagnosis of DRESS syndrome is mainly clinical, the clinicians have to play the crucial role for prompt clinical recognition and discontinuing suspected medicines which will help to minimise the morbidity and mortality associated with this syndrome.
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